79 related articles for article (PubMed ID: 5317332)
1. [Antistaphylococcic activity, protective activity in vivo and blood levels in man of triacetyl-oleandomycin and erythromycin].
Colitti G; Liani M; Stella F
Antibiotica; 1970; 8(2):216-25. PubMed ID: 5317332
[No Abstract] [Full Text] [Related]
2. Therapy of staphylococcal infections in monkeys. IV. Further comparison of triacetyloleandomycin and erythromycins.
Saslaw S; Carlisle HN; Marietti M
Appl Microbiol; 1969 Dec; 18(6):1077-83. PubMed ID: 4984259
[TBL] [Abstract][Full Text] [Related]
3. [Antibacterial activity in vitro and in vivo and blood levels in man of two antibiotics of the macrolid group: lincomycin and triacetyloleandomycin].
Ciaffi G; Colitti A; Renzini G
Antibiotica; 1970; 8(2):206-15. PubMed ID: 4949768
[No Abstract] [Full Text] [Related]
4. Serum antibacterial activity after oral suspensions and capsules of triacetyloleandomycin and erythromycin estolate.
Saslaw S; Carlisle HN
Appl Microbiol; 1970 Feb; 19(2):370-4. PubMed ID: 5309528
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione.
Pessayre D; Tinel M; Larrey D; Cobert B; Funck-Brentano C; Babany G
J Pharmacol Exp Ther; 1983 Mar; 224(3):685-91. PubMed ID: 6600790
[TBL] [Abstract][Full Text] [Related]
6. The microbiological characteristics of troleandomycin.
Cocuzza G
Quad Antibiot; 1975 Jun; ():18-34. PubMed ID: 1088736
[No Abstract] [Full Text] [Related]
7. [Effect of reaction of medium and anaerobic conditions on the action of oletetrine (sigmamycin) and the combination of erythromycin with tetracycline].
Bass TM
Antibiotiki; 1970 Jul; 15(7):643-5. PubMed ID: 5479696
[No Abstract] [Full Text] [Related]
8. [Blood and tissue levels of oleandomycin in man as consequence of administration by oral route of triacetyloleandomycin].
Liani M; Porzio R; Porzio D
Antibiotica; 1968 Dec; 6(4):368-74. PubMed ID: 5309023
[No Abstract] [Full Text] [Related]
9. The pharmacological and pharmacokinetic properties of troleandomycin.
Genazzani E
Quad Antibiot; 1975 Jun; ():35-56. PubMed ID: 210708
[No Abstract] [Full Text] [Related]
10. Erythromycin pharmacokinetics in man.
Houin G; Tillement JP; Lhoste F; Rapin M; Soussy CJ; Duval J
J Int Med Res; 1980; 8 Suppl 2():9-14. PubMed ID: 7429008
[TBL] [Abstract][Full Text] [Related]
11. [Effect of triacetyloleandomycin, erythromycin and spiramycin on mono-oxygenase activity].
Micheva M; Stoĭchev Ts
Eksp Med Morfol; 1984; 23(1):28-33. PubMed ID: 6332004
[No Abstract] [Full Text] [Related]
12. [Concentration of antibiotics in various jaw tissues: concentration of erythromycin (2)].
Pignanelli M; Loiaconi G; Santoro F; Scaglione F; Fraschini F
Dent Cadmos; 1981 Nov; 49(11):27-32. PubMed ID: 6959835
[No Abstract] [Full Text] [Related]
13. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
14. Chemical modification of erythromycin antibiotics. 4. Structure-activity relationships of erythromycin esters.
Martin YC; Jones PH; Perun TJ; Grundy WE; Bell S; Bower RR; Shipkowitz NL
J Med Chem; 1972 Jun; 15(6):635-8. PubMed ID: 4555493
[No Abstract] [Full Text] [Related]
15. Depression of theophylline metabolism and elimination by troleandomycin and erythromycin.
Hemsworth TC; Renton KW
Biochem Pharmacol; 1981 Jun; 30(11):1299-304. PubMed ID: 6973975
[No Abstract] [Full Text] [Related]
16. [Clinical trials on the anti-inflammatory activity of an antibiotic of the macrolide group: triacetyl-oleandomycin (T.A.O.) in an emergency traumatic pathology department].
Arcadio F; Caton J; Mesguich A
Lyon Med; 1970 Mar; 223(10):597-602. PubMed ID: 5309600
[No Abstract] [Full Text] [Related]
17. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI
Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of the antibiotic activity of erythromycin in plasma medium.
Yourassowsky E
Chemotherapy; 1966; 11(6):338-44. PubMed ID: 5971541
[No Abstract] [Full Text] [Related]
19. [Bacteriostatic activity exhibited by oleandomycin, triacetyl oleandomycin and spiramycin on mycobacteria].
VIALLIER J; AUGAGNEUR J
C R Seances Soc Biol Fil; 1962; 156():1435-7. PubMed ID: 13997027
[No Abstract] [Full Text] [Related]
20. [Development of resistance toward oletetrin (sigmamycin) in staphylococci].
Bass TM
Antibiotiki; 1966 Oct; 11(10):950-2. PubMed ID: 5997601
[No Abstract] [Full Text] [Related]
[Next] [New Search]
